Stockscreener 앱 받기
40.08
0.55%
-0.16
전일 마감가:
$40.24
열려 있는:
$40.89
하루 거래량:
177.39K
Relative Volume:
0.35
시가총액:
$734.14M
수익:
$1.77M
순이익/손실:
$-123.74M
주가수익비율:
-4.3708
EPS:
-9.17
순현금흐름:
$-95.21M
1주 성능:
+9.91%
1개월 성능:
+22.57%
6개월 성능:
-44.97%
1년 성능:
-26.62%
1일 변동 폭
$38.74
$40.89
1주일 범위
$35.42
$40.89
52주 변동 폭
$26.70
$91.83
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
명칭
Praxis Precision Medicines Inc
전화
617-300-8460
주소
99 HIGH STREET, 30TH FLOOR, BOSTON
PRAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
40.08 | 734.14M | 1.77M | -123.74M | -95.21M | -9.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.11 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.89 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.45 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.00 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.73 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-03 | 재확인 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-08-05 | 개시 | Oppenheimer | Outperform |
| 2024-06-24 | 개시 | Needham | Buy |
| 2024-06-18 | 개시 | Guggenheim | Buy |
| 2024-05-01 | 개시 | Robert W. Baird | Outperform |
| 2023-09-19 | 개시 | Truist | Buy |
| 2022-06-06 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-12-16 | 개시 | H.C. Wainwright | Buy |
| 2021-08-26 | 개시 | BofA Securities | Buy |
| 2021-04-26 | 개시 | William Blair | Outperform |
| 2020-11-11 | 개시 | Wedbush | Outperform |
| 2020-11-10 | 개시 | Cowen | Outperform |
| 2020-11-10 | 개시 | Evercore ISI | Outperform |
| 2020-11-10 | 개시 | Piper Sandler | Overweight |
모두보기
Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스
Wedbush Adjusts Price Target for Praxis Precision Medicine (PRAX) | PRAX Stock News - GuruFocus
PRAX Stock Target Increased by Baird Amid Positive Epilepsy Drug Outlook | PRAX Stock News - GuruFocus
Wedbush Lifts Price Target on Praxis Precision Medicines to $28 From $26, Keeps Underperform Rating - marketscreener.com
PRAX Unveils Progress in DEE Clinical Programs | PRAX Stock News - GuruFocus
Praxis Precision Medicines Highlights DEE Clinical Program Updates at Virtual Investor Event - The Manila Times
Clinical Trial Success: Praxis's DEE Drug Cuts Seizures by 90%, Eyes $3B Market Opportunity - Stock Titan
Praxis Precision Medicine (PRAX): Buy Rating Reiterated by Needham | PRAX Stock News - GuruFocus
Praxis Precision Medicines First Quarter 2025 Earnings: US$3.29 loss per share (vs US$2.85 loss in 1Q 2024) - Yahoo Finance
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PRAX Stock News - GuruFocus
Praxis Precision Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - marketscreener.com
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Praxis Precision Medicines Awards 3,688 Restricted Stock Units to 5 New Non-Executive Hires - Stock Titan
Praxis Precision Medicines Provides Corporate Update and Reports - GuruFocus
PRAX Revenue Falls Short as Company Focuses on Epilepsy Portfoli - GuruFocus
PRAX Revenue Falls Short as Company Focuses on Epilepsy Portfolio | PRAX Stock News - GuruFocus
Praxis Precision Medicines, Inc. SEC 10-Q Report - TradingView
Praxis Precision Medicines Reports Significant Progress and Upcoming Milestones in Epilepsy Portfolio - Nasdaq
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2025 Financial Results - Yahoo Finance
Wells Fargo & Company MN Boosts Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Assessing Praxis Precision Medicine: Insights From 8 Financial Analysts - Benzinga
PRAX: HC Wainwright Reiterates Buy Rating and $105 Price Target | PRAX Stock News - GuruFocus
Praxis Precision Medicines Inc (PRAX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
A closer look at Praxis Precision Medicines Inc (PRAX) is warranted - uspostnews.com
JPMorgan Chase & Co. Has $746,000 Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Praxis Precision Medicines (NASDAQ:PRAX) vs. Dr. Reddy’s Laboratories (NYSE:RDY) Head to Head Comparison - Defense World
How To Trade (PRAX) - news.stocktradersdaily.com
Financial Review: Praxis Precision Medicines (NASDAQ:PRAX) & ABIVAX Société Anonyme (NASDAQ:ABVX) - Defense World
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Geode Capital Management LLC Has $31.31 Million Stock Position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Contrasting Praxis Precision Medicines (NASDAQ:PRAX) & Generex Biotechnology (OTCMKTS:GNBT) - Defense World
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
Alliancebernstein L.P. Buys 60,587 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Purchased by American Century Companies Inc. - Defense World
Vanguard Group Inc. Buys 24,645 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Sodium Channel Blockers Clinical Trial Pipeline Accelerates as 20+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Is Praxis Precision Medicines Inc (PRAX) a good investment opportunity? - uspostnews.com
Norges Bank Purchases New Stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Praxis Precision Medicines to Hold Virtual Investor Event - GlobeNewswire
Deep Dive Into Praxis Precision Medicine Stock: Analyst Perspectives (8 Ratings) - Benzinga
Major Clinical Updates: Praxis Unveils New Data from 3 Rare Epilepsy Programs - Stock Titan
KLP Kapitalforvaltning AS Buys Shares of 2,800 Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
Critical Survey: Praxis Precision Medicines (NASDAQ:PRAX) versus Sycamore Entertainment Group (OTCMKTS:SEGI) - Defense World
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Sold by Corebridge Financial Inc. - Defense World
PRAX stock touches 52-week low at $30 amid market challenges - Investing.com India
How to Take Advantage of moves in (PRAX) - news.stocktradersdaily.com
Praxis Precision Medicines to Participate in Upcoming April Conferences - The Manila Times
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener
CNS Drug Developer Praxis Sets Key Investor Presentations at Needham and Piper Conferences - Stock Titan
Teacher Retirement System of Texas Invests $305,000 in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Defense World
We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Shares Purchased by Swiss National Bank - Defense World
Praxis Precision Medicines Inc (PRAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Praxis Precision Medicines Inc 주식 (PRAX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Nemiroff Alex | General Counsel and Secretary |
Nov 14 '24 |
Sale |
80.20 |
8,239 |
660,827 |
10,301 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Option Exercise |
56.94 |
4,374 |
249,056 |
10,801 |
| Mastrocola Lauren | Principal Accounting Officer |
Nov 14 '24 |
Sale |
81.78 |
5,188 |
424,318 |
5,613 |
0.27%
0.30%
자본화:
|
볼륨(24시간):